ARS Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
27 Mar 24 | BuyUS$13,289,410 | RA Capital Management, L.P. | Company | 1,401,299 | US$9.79 | |
29 Sep 23 | BuyUS$319,954 | Alexander Fitzpatrick | Individual | 86,258 | US$3.78 | |
21 Sep 23 | BuyUS$8,183,526 | RA Capital Management, L.P. | Company | 2,700,000 | US$3.83 | |
29 Aug 23 | SellUS$26,350,000 | Robert Bell | Individual | 4,250,000 | US$6.20 | |
29 Aug 23 | BuyUS$3,100,000 | OrbiMed Advisors LLC | Company | 500,000 | US$6.20 | |
29 Aug 23 | BuyUS$23,250,000 | RA Capital Management, L.P. | Company | 3,750,000 | US$6.20 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,296,177 | 3.4% |
Hedge Funds | 11,077,927 | 11.4% |
General Public | 13,381,909 | 13.8% |
Individual Insiders | 19,490,631 | 20.1% |
VC/PE Firms | 20,101,864 | 20.7% |
Institutions | 29,546,748 | 30.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,077,927 | US$91.3m | 0% | 1.74% | |||
10,860,977 | US$89.5m | 14.8% | 1.23% | |||
9,240,887 | US$76.1m | 0% | 1.1% | |||
5,861,807 | US$48.3m | -24.6% | no data | |||
4,824,554 | US$39.8m | -52.5% | no data | |||
4,213,504 | US$34.7m | 0% | no data | |||
4,012,903 | US$33.1m | 0% | 9.71% | |||
3,407,847 | US$28.1m | 4% | no data | |||
3,295,946 | US$27.2m | 94.2% | no data | |||
2,950,709 | US$24.3m | -28% | 0.01% | |||
2,886,455 | US$23.8m | 37% | no data | |||
2,658,239 | US$21.9m | 0.78% | no data | |||
2,219,131 | US$18.3m | -27.3% | 9.84% | |||
1,910,029 | US$15.7m | 0% | 2.62% | |||
1,604,550 | US$13.2m | 178% | no data | |||
1,084,922 | US$8.9m | -9.76% | no data | |||
876,671 | US$7.2m | 1.36% | no data | |||
867,319 | US$7.1m | 0% | 0.15% | |||
639,203 | US$5.3m | 0% | 0.11% | |||
638,980 | US$5.3m | 0% | 0.31% | |||
558,700 | US$4.6m | 17.9% | 0.04% | |||
536,163 | US$4.4m | -51.5% | 1.66% | |||
401,788 | US$3.3m | -39.3% | 0.03% | |||
399,528 | US$3.3m | 16,800% | no data | |||
382,236 | US$3.1m | 0% | no data |